Streetbeat News

Earnings

NOVT

Novanta expects its Q3 GAAP revenue to be between $221M-$224M, lower than the estimated $229.58M. The company also anticipates its adjusted EPS to be between $0.70-$0.77, which is below the estimated $0.82.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 11:08 am

GLBE

Global-e Online Ltd has updated its Q3 revenue forecast to $136M-$142M, which is lower than the estimated $142.57M. The company also revised its FY23 revenue projection to $570M-$596M, slightly higher than the previous range of $562M-$590M, but still below the estimated $583.28M.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 11:08 am

ADCT

ADC Therapeutics has projected a double-digit percentage growth in net product sales for the fiscal year 2023.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 11:08 am

CECO

CECO Environmental reported Q2 adjusted earnings of $0.15 per share, missing the analyst consensus estimate of $0.17 by 11.76%. This is a 16.67% decrease from the same period last year. However, the company reported quarterly sales of $129.18 million, beating the analyst consensus estimate of $116.68 million by 10.71%, a 22.59% increase from last year.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 11:08 am

CLBT

Cellebrite DI (NASDAQ:CLBT) reported Q2 earnings of $0.05 per share, beating the analyst consensus estimate of $0.03 by 66.67%. The company also reported quarterly sales of $76.68 million, surpassing the analyst consensus estimate of $72.46 million by 5.82%. This represents a 22.54% increase over sales of $62.57 million in the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 11:07 am

FUSN

Fusion Pharmaceuticals (NASDAQ:FUSN) reported Q2 losses of $(0.38) per share, beating the analyst consensus estimate of $(0.39) by 2.56 percent. However, the company's quarterly sales of $34.00 thousand missed the analyst consensus estimate of $80.00 thousand by 57.50 percent, marking a 94.04 percent decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 11:07 am

NSPR

InspireMD reported Q2 losses of $(0.24) per share, beating the analyst consensus estimate of $(0.30) by 20%. The company also reported quarterly sales of $1.65 million, beating the analyst consensus estimate of $1.55 million by 6.39%. This represents a 59.32% increase in losses and a 7.71% increase in sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 11:07 am

STGW

Stagwell (NASDAQ:STGW) reported Q2 earnings of $0.16 per share, missing the analyst consensus estimate of $0.20 by 20%. The company also reported quarterly sales of $632.26 million, missing the analyst consensus estimate of $658.88 million by 4.04%. This represents a 6.04% decrease over sales of $672.91 million the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 11:06 am

TGLS

Tecnoglass reported Q2 adjusted earnings of $1.12 per share, beating the analyst consensus estimate of $0.98 by 14.29%. This is a 62.32% increase from the same period last year. The company also reported quarterly sales of $225.28 million, beating the analyst consensus estimate of $208.90 million by 7.84%, a 33.20% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 11:06 am

BITF

Bitfarms (NASDAQ:BITF) reported Q2 losses of $(0.10) per share, missing the analyst consensus estimate of $(0.05) by 100%. However, the company's quarterly sales of $35.48 million beat the estimate of $34.10 million by 4.04%.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 11:06 am